Pathologi Gbs
Pathologi Gbs
Pathologi Gbs
Neuroimmunology
Clinical and Experimental Neuroimmunology 7 (2016) 312–319
REVIEW ARTICLE
syndrome
Pathology of Guillain–Barre
Yuta Nakano and Takashi Kanda
Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan
Keywords Abstract
acute inflammatory demyelinating polyradicu- Guillain–Barr e syndrome (GBS), a disease affecting the peripheral nervous
loneuropathy; acute motor and sensory axonal
system, is now well known. However, the disease concept has evolved over
neuropathy; acute motor axonal neuropathy;
successive periods. For example, for approximately nine decades from the
Guillain–Barr
e syndrome; pathology
first report of GBS, it was considered to have a spinal cord origin. After the
Correspondence first clinical report, the accumulation of detailed clinicopathological data
Takashi Kanda, MD, PhD, Department of Neu- showed that GBS is composed of two distinct clinicopathological entities:
rology and Clinical Neuroscience, Yamaguchi acute inflammatory demyelinating polyneuropathy, and acute motor axonal
University Graduate School of Medicine, 1-1-1 neuropathy or acute motor and sensory axonal neuropathy. Acute inflam-
Minamikogushi, Ube, Yamaguchi 755-8505,
matory demyelinating polyneuropathy is characterized by the patchy distri-
Japan.
bution of demyelinative foci throughout the peripheral nervous system,
Tel: +81-836-22-2714
Fax: +81-836-22-2364 whereas acute motor axonal neuropathy/acute motor and sensory axonal
Email: tkanda@yamaguchi-u.ac.jp neuropathy shows primary axonal degeneration in the peripheral nervous
system, which is particularly accentuated at the spinal nerve roots. The pur-
Received: 15 September 2016; revised: pose of the present article was to provide an overview of the previous pub-
26 September 2016; accepted: 26 September lications regarding the pathology of GBS and to thereby elucidate the
2016.
pathological mechanisms of this still threatening disorder from a pathologi-
cal viewpoint. The critical pathological feature of acute inflammatory
demyelinating polyneuropathy is the complement–macrophage-induced
cytotoxic damage on the plasmalemma of the Schwann cells, whereas that
of acute motor axonal neuropathy/acute motor and sensory axonal neu-
ropathy is the antibody–complement-mediated immune attack on the axo-
lemma at the nodes of Ranvier.
Figure 2 The vagus nerve. Some almost intact myelinated fibers and Figure 4 A completely denuded axon surrounded by macrophages
demyelinated fibers at the various degenerative phases. Scale bar, with a large amount of myelin debris, penetrating the Schwann cell
10 lm. Reproduced from Nakano et al.30 with permission. basal membrane. A, axon; M, macrophage; S, Schwann cell. Scale bar,
1 lm. Reproduced from Nakano et al.30 with permission.
interperiod line by the cytoplasmic process of the (n = 3), IgM deposition around the Schwann cell
phagocytes, which contained a small number of surface (n = 1), and IgG deposition within the endo-
organelles in contrast with their cell body. Just two neurium (n = 1).18
biopsy cases showed vesicular degeneration. After In 1991, Honavar studied nine post-mortem GBS
that report, 65 biopsy cases of GBS were reported by patients.21 Frozen sections of the peripheral nerve
Brechenmacher in 1987; with just eight cases pre- were available for immunological analysis in one
senting vesicular degeneration.18 These authors case. A striking increase in the numbers of leuko-
regarded vesicular degeneration, a rare pathological cytes (mainly T cells) and macrophages was seen in
change among biopsy cases, as an autopsy-related both the endoneurium and the perineurium.
artifact. These biopsy specimens showed only sparse In 1996, a detailed immunohistochemical analysis
inflammatory infiltration. using well-preserved autopsy tissues from three
In 1989, Kanda et al.19 documented a fulminant acute AIDP cases with clinical courses of 3, 8 and
case of AIDP. The patient died on the 8th day after 9 days, respectively, were reported by Hafer-Macko
the onset of symptoms, and an autopsy was carried et al.22 In all three cases, the spinal roots were
out at 3 h after the patient’s death. Demyelination found to be the most severely involved component
with intact axons was observed throughout the of the PNS. In the 3-day case, mild internodal
examined segments of the PNS with abundant demyelination was found, and the infiltration of
macrophages, in contrast to the lymphocytes, which lymphocytes and macrophages was sparse and pat-
were scarce. chy. In contrast, both the 8-day and 9-day cases
The process of demyelination in AIDP seemed to showed severe demyelination and extensive infiltra-
be strongly affected by the penetration of mononu- tion by lymphocytes and macrophages. These
clear cells, probably macrophages rather than lym- changes were more conspicuous in the 9-day case.
phocytes. They invade the Schwann cell basement In the 3-day and 8-day cases, C3d and C5b-9 depos-
membrane and peel off the outer myelin lamellae its were found on the outer surface of the Schwann
through a cytoplasmic process. Although the signifi- cells. The degree of deposition was less prominent
cance of the vesicular degeneration remains contro- in the 9-day case. In comparison with their ultra-
versial, it might be the initial change of the structural findings, the C3d-immunostained fibers
demyelination of AIDP. corresponded to the fibers that presented vesicular
degeneration, and advanced demyelinated fibers
lacked C3d immunoreactivity. The macrophages
What is the immunological target in AIDP?
were mainly involved in the advanced demyelina-
The importance of mononuclear cells in the demyeli- tion; however, in the earlier stage of demyelination,
native process in AIDP gave rise to the need for the when the Schwann cells were encircled by C3d
precise discrimination of the profile of these cells, immunoreactivity and presented outermost vesicular
and the detection of their accurate target by degeneration, their participation was slight. Patho-
immunohistochemistry. logical immunoreactivity against IgG or IgM was not
In 1981, Nyland et al.20 carried out an immuno- observed.
logical analysis of eight sural nerve biopsy specimens These pathological findings suggest that the tar-
from GBS patients. In acute cases in which the dura- get of AIDP is not the cytoplasm, but the plas-
tion of symptoms was <12 weeks, only sparse malemma of the Schwann cells. In the presence of
inflammatory cell infiltration was observed in the lymphocytes, mainly T cells, the blood–nerve bar-
endoneurium. In contrast, all of the chronic cases, in rier (BNB) was broken, and humoral factors
which the duration was ≥12 weeks, showed signifi- entered the PNS parenchyma. The binding of com-
cant infiltration. The deposition of complement com- plements to the outer surface of the Schwann cells
ponent 3 (C3) was detected within the endoneurium induced the vesicular degeneration of superficial
in four patients, and the deposition of immunoglob- myelin lamellae. Finally, migrated macrophages
ulin G (IgG) and immunoglobulin M (IgM) was attacked the damaged myelin sheath, penetrated
found in two patients, mainly along the myelin the Schwann cell basement membrane, stripped
sheath. the outermost myelin lamellae at the interperiod
Brechenmacher carried out immunohistochemical lines through their cytoplasmic process and acceler-
examinations of 17 of their 65 biopsy cases, and ated the demyelination. Throughout this demyeli-
abnormal findings were observed in four specimens: native process, no specific antibodies were
perivascular deposition of IgG or IgM and C3 detected.
(a) (b)
(c) (d)
(e) (f)
of them, primary axonal degeneration was con- 2. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal
firmed, and the lengthened nodes of Ranvier and form of Guillain-Barre polyneuropathy. Brain. 1986; 109:
periaxonal macrophages were present. The axo- 1115–26.
lemma at the nodes of Ranvier was strongly stained 3. Griffin JW, Li CY, Ho TW, et al. Guillain-Barre syndrome
by the complement activation product, C3d. These in northern China. The spectrum of neuropathological
nodes were mostly enlarged. The internodal axo- changes in clinically defined cases. Brain. 1995; 118:
lemma also showed intense immunoreactivity with 577–95.
the terminal complement complex, C5b-9 and IgG, 4. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-
sensory axonal Guillain-Barre syndrome. Ann Neurol.
but not IgM. The immunoreactivity tended to
1996; 39: 17–28.
become weakened, according to the progress of the
5. Griffin JW, Li CY, Macko C, et al. Early nodal changes in
axonal degeneration. Through these observations,
the acute motor axonal neuropathy pattern of the Guil-
the binding of the complements and immunoglobu-
lain-Barre syndrome. J Neurocytol. 1996; 25: 33–51.
lin, presumably IgG, to the surface of the internodal
6. Sobue G, Li M, Terao S, et al. Axonal pathology in Japa-
axolemma was the initial event of the axonal disin- nese Guillain-Barre syndrome: a study of 15 autopsied
tegrative process. cases. Neurology. 1997; 48: 1694–700.
The humoral factors, including immunoglobulin 7. Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axo-
and complements, attacked the PNS, mainly at the nal neuropathy: an antibody-mediated attack on axo-
spinal roots, where the BNB was physiologically vul- lemma. Ann Neurol. 1996; 40: 635–44.
nerable, and these agents bound to the internodal 8. Guillain G, Barre JA, Strohl A. Sur un syndrome de
axolemma. The macrophages attached to the dam- radiculonevrite avec hyperalbuminose du liquide
aged axolemma, penetrated the Schwann cell base- cephalo-rachidien sans reaction cellulaire: remarques
ment membrane, and invaginated the periaxonal surles caracteres cliniques et graphiques des reflexes
space. Eventually, the consequential axonal damage tendineux. Bull Soc Med Ho ^p Paris. 1916; 40: 1462–70.
progressed into Wallerian degeneration. 9. Dejerine J. Notes sur un cas de paralysie ascendante
aigu€e. Arch Physiol. 1876; 8: 312–7.
10. Eichhorst H. Neuritis acuta progressive. Virchows Arch. f.
Future directions path. Anat. 1876; 69: 265.
GBS is composed of two distinct disease entities: 11. Van der Velden R. Ein fall von akuter aufsteigender spi-
AIDP and the axonal form of GBS. The pathologi- naler paralyse. Deutsche Arch f kiln Med. 1877; 19: 333.
cally significant feature of AIDP is the complement– 12. Prineas JW. Pathology of the Guillain-Barre syndrome.
macrophage-induced cytotoxic damage on the plas- Ann Neurol. 1981; 9: 6–19.
13. Haymaker W, Kernohan JW. The Landry-Guillain-Barre
malemma of the Schwann cells, whereas that of the
syndrome. A clinicopathologic report of fifty fatal cases
latter is the antibody–complement-mediated
and a critique of the literature. Medicine (Baltimore).
immune attack on the axolemma at the nodes of
1949; 28: 59–141.
Ranvier. The development of novel therapies for
14. Asbury AK, Arnason BG, Adams RD. The inflammatory
GBS is highly expected based on these two patholog-
lesion in idiopathic polyneuritis. Its role in pathogenesis.
ical mechanisms. However, we now consider the Medicine (Baltimore). 1969; 48: 173–215.
upstream site of pathogenesis, BNB, to be more 15. Wisniewski H, Terry RD, Whitaker JN, et al. Landry-Guil-
important for overcoming this disorder. For this pur- lain-Barre syndrome. A primary demyelinating disease.
pose, we have established human peripheral nerve Arch Neurol. 1969; 21: 269–76.
microvascular endothelial and pericyte cell lines to 16. Carpenter S. An ultrastructural study of an acute fatal
construct an in vitro model of BNB.28,29 Through case of the Guillain-Barre syndrome. J Neurol Sci. 1972;
these efforts, we hope that GBS will be successfully 15: 125–40.
treated in the near future. 17. Prineas JW. Acute idiopathic polyneuritis. An electron
microscope study. Lab Invest. 1972; 26: 133–47.
18. Brechenmacher C, Vital C, Deminiere C, et al. Guil-
Conflict of interest
lain-Barre syndrome: an ultrastructural study of periph-
None declared. eral nerve in 65 patients. Clin Neuropathol. 1987; 6:
19–24.
19. Kanda T, Hayashi H, Tanabe H, et al. A fulminant case of
References Guillain-Barre syndrome: topographic and fibre size
1. Landry O. Note sur la paralysie ascendante aigu€e. Gaz related analysis of demyelinating changes. J Neurol Neu-
Hebd Med Chir. 1859; 6: 472–4, 486–8. rosurg Psychiatry. 1989; 52: 857–64.
20. Nyland H, Matre R, Mørk S. Immunological characteriza- flaccid paralysis in China. Ann Neurol. 1993; 33: 333–
tion of sural nerve biopsies from patients with Guillain- 42.
Barre syndrome. Ann Neurol. 1981; 9: 80–6. 26. Paradiso G, Tripoli J, Galicchio S, et al. Epidemiological,
21. Honavar M, Tharakan JK, Hughes RA, et al. A clinico- clinical, and electrodiagnostic findings in childhood Guil-
pathological study of the Guillain-Barre syndrome. lain-Barre syndrome: a reappraisal. Ann Neurol. 1999; 46:
Nine cases and literature review. Brain. 1991; 114: 701–7.
1245–69. 27. Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-
22. Hafer-Macko CE, Sheikh KA, Li CY, et al. Immune attack on Barre syndrome: relation to anti-ganglioside antibodies
the Schwann cell surface in acute inflammatory demyeli- and Campylobacter jejuni infection in Japan. Ann Neurol.
nating polyneuropathy. Ann Neurol. 1996; 39: 625–35. 2000; 48: 624–31.
23. Hadden RD, Cornblath DR, Hughes RA, et al. Electro- 28. Abe M, Sano Y, Maeda T, et al. Establishment and char-
physiological classification of Guillain-Barre syndrome: acterization of human peripheral nerve microvascular
clinical associations and outcome. Plasma Exchange/San- endothelial cell lines: a new in vitro blood-nerve barrier
doglobulin Guillain-Barre Syndrome Trial Group. Ann (BNB) model. Cell Struct Funct. 2012; 37: 89–100.
Neurol. 1998; 44: 780–8. 29. Shimizu F, Sano Y, Abe MA, et al. Peripheral nerve peri-
24. McKhann GM, Cornblath DR, Ho T, et al. Clinical and cytes modify the blood-nerve barrier function and tight
electrophysiological aspects of acute paralytic disease of junctional molecules through the secretion of various
children and young adults in northern China. Lancet. soluble factors. J Cell Physiol. 2011; 226: 255–66.
1991; 338: 593–7. 30. Nakano Y, Kanda T. Pathology of the peripheral nervous
25. McKhann GM, Cornblath DR, Griffin JW, et al. Acute system in Guillain-Barre syndrome. Brain Nerve. 2015; 67:
motor axonal neuropathy: a frequent cause of acute 1329–39. (in Japanese).